EN-002

N/A

Report date: 2022/05/30 20:00:35
NME

Base Information

Drug NameEN-002
Drug Alias NameEN-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA Replication Initiation Proteins inhibitors
TargetsDNA Replication Initiation Proteins
Therapy Area/IndicationsSkin Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEnkang Pharmaceutical Technology (Guangzhou) Co Ltd2y-Biopharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesEnkang Pharmaceutical Technology (Guangzhou) Co Ltd2y-Biopharma
Inactive CompaniesN/A
Active IndicationsSkin Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A